Evan Jayang Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Evan Jayang Wang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Brian Yu-Ting Kuo
Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804201, Taiwan
1 shared publicationChia-Cheng Yu
Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung 813405, Taiwan
1 shared publicationChih-Mei Chen
Human Genetic Center, China Medical University Hospital, Taichung 404327, Taiwan
1 shared publicationI-Hsuan Chen
Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung 813405, Taiwan
1 shared publicationJen-Tai Lin
Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung 813405, Taiwan
1 shared publication- Jim Jinn-Chyuan Sheu
Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan
1 shared publication
Latest Publications
- Open Access
- 13 December 2022
- Published by MDPI AG in Biomolecules
- Vol. 12 (12) , 1862
Alterations of Cytoskeleton Networks in Cell Fate Determination and Cancer Development
Cytoskeleton proteins have been long recognized as structural proteins that provide the necessary mechanical architecture for cell development and tissue homeostasis. With the completion of the cancer genome project, scientists were surprised to learn that huge numbers of mutated genes are annotated as cytoskeletal or associated proteins. Although most of these mutations are considered as passenger mutations during cancer development and evolution, some genes show high mutation rates that can even determine clinical outcomes. In addition, (phospho)proteomics study confirms that many cytoskeleton-associated proteins, e.g., β-catenin, PIK3CA, and MB21D2, are important signaling mediators, further suggesting their biofunctional roles in cancer development. With emerging evidence to indicate the involvement of mechanotransduction in stemness formation and cell differentiation, mutations in these key cytoskeleton components may change the physical/mechanical properties of the cells and determine the cell fate during cancer development. In particular, tumor microenvironment remodeling triggered by such alterations has been known to play important roles in autophagy, metabolism, cancer dormancy, and immune evasion. In this review paper, we will highlight the current understanding of how aberrant cytoskeleton networks affect cancer behaviors and cellular functions through mechanotransduction.
- 13 December 2022
- Published by MDPI AG in Biomolecules
- Vol. 12 (12) , 1862
Open AccessAlterations of Cytoskeleton Networks in Cell Fate Determination and Cancer Development
Cytoskeleton proteins have been long recognized as structural proteins that provide the necessary mechanical architecture for cell development and tissue homeostasis. With the completion of the cancer genome project, scientists were surprised to learn that huge numbers of mutated genes are annotated as cytoskeletal or associated proteins. Although most of these mutations are considered as passenger mutations during cancer development and evolution, some genes show high mutation rates that can even determine clinical outcomes. In addition, (phospho)proteomics study confirms that many cytoskeleton-associated proteins, e.g., β-catenin, PIK3CA, and MB21D2, are important signaling mediators, further suggesting their biofunctional roles in cancer development. With emerging evidence to indicate the involvement of mechanotransduction in stemness formation and cell differentiation, mutations in these key cytoskeleton components may change the physical/mechanical properties of the cells and determine the cell fate during cancer development. In particular, tumor microenvironment remodeling triggered by such alterations has been known to play important roles in autophagy, metabolism, cancer dormancy, and immune evasion. In this review paper, we will highlight the current understanding of how aberrant cytoskeleton networks affect cancer behaviors and cellular functions through mechanotransduction.